Gel Documentation Systems Market Overview, Prediction Analysis, Competitive Landscape, Demand, Technology Assessment, Top Vendors, and Forecast to 2023

Market Overview:
The global gel documentation systems market was valued at USD 245 Mn and is expected to expand at a CAGR of 3.6% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in a detailed study.
Infectious diseases and genetic disorders are on the rise currently. Gel documentation systems find potential application in the molecular biology which includes nucleic acid isolation or amplification for molecular cloning techniques, gene silencing, gene modulation, and gene expression.
Rise in genomic research and a growing emphasis on personalized medicine and synthetic biology is also a key factor enhancing the growth of the global gel documentation systems market. Gel documentation systems provide flexibility and ease of use in imaging nucleic acid and protein gels due to which they are gaining traction among research studies. The rise in a number of research laboratories, diagnostic centers, clinical and medical institutions have contributed positively to the growth of the global gel documentation systems market.
On the flip side, high costs associated with gel documentation systems is likely to restrain the growth of the global gel documentation systems market. Most commercial gel documentation systems available in the market are not affordable in developing countries where the growth of the market is imopeded due to price sensitivity.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6908
Competitive Landscape:
·         GE Healthcare
·         Azure Biosystems
·         Scientific Digital Imaging Plc.
·         Thermo Fisher Scientific
·         LI-COR Biosciences
·         Bio-Techne, Endress + Hauser Management AG
·         Cleaver Scientific
·         Bio-Rad Laboratories
·         Vilber Lourmat

Segmentation:
·         The global gel documentation systems market has been segmented based on product, detection techniques, application, and end user.
·         By product, the global gel documentation systems market has been segmented into accessories, instruments, and software. The instrument segment has been further segmented into film gel documentation instruments and digital gel documentation instruments. Increasing R&D activities within the biotechnology and pharmaceutical industries boost the growth of the instruments segment which accounts for the maximum share of the market.
·         By detection technique, the global gel documentation systems market has been segmented into ultraviolet, chemiluminescence, and fluorescence.
·         By application, the global gel documentation systems market has been segmented into protein quantification, nucleic acid quantification, and others.
·         By end user, the global gel documentation systems market has been segmented into pharmaceutical & biotechnology companies, diagnostic laboratories, academic institutes & research centers, and others.

Regional Analysis:
By region, the global gel documentation systems market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
The Americas account for the maximum share of the global gel documentation systems market. Expansion of clinical R&D budgets by biotechnology and pharmaceutical companies accompanied by government support in the form of R&D grants boosts the growth of the gel documentation systems market. In addition, the region is a frontrunner in the adoption of advanced technology within the healthcare sector which acts as a plus for the growth of the market.
Europe commands the second position in the global gel documentation systems market. Robust academic & research base and availability of funds for research can be credited for the growth of the Europe market.
Higher emphasis on biomedical and biotechnology sector and rise in a number of proteomic and genomic studies have helped APAC establish itself as a significant market for gel documentation systems. APAC is slated to register the highest CAGR over the forecast period.
The Middle East holds the major share of the MEA gel documentation systems market due to the improvement of the healthcare sector in the region. The Africa market is likely to showcase limited growth due to low healthcare penetration.

Industry Updates:
In February 2018, Syngene, Asia's largest contract research & manufacturing organization, introduced a new gel documentation system, the InGenius3. The new gel doc system features integrated to a compact light-tight darkroom, and overhead Epi LED white lighting for perfect gel positioning and a 3 million pixel CCD camera.

Access Full Report Details and TOC Exclusively @ https://www.marketresearchfuture.com/reports/gel-documentation-systems-market-6908
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more